NextCell Pharma AB (OSTO:NXTCL) Other Income (Expense) : kr-0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Other Income (Expense)?

NextCell Pharma AB's other income expense for the NextCell Pharma AB's pretax income for the three months ended in Feb. 2024 was kr0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Feb. 2024 was kr-0.00 Mil.

NextCell Pharma AB Other Income (Expense) Historical Data

The historical data trend for NextCell Pharma AB's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Other Income (Expense) Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Other Income (Expense)

Get a 7-Day Free Trial

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Income (Expense)	Get a 7-Day Free Trial															-	-	-	-	-

NextCell Pharma AB Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.00 Mil.

NextCell Pharma AB (OSTO:NXTCL) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines